Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Investor Information
Home
>
Investor Information
>
Investor Presentations
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Investor Presentations
23-Feb-2023
ATX - US Conference Presentation
9-Feb-2023
Amplia Therapeutics - Lorne Cancer Conference Presentation
20-Dec-2022
ATX - 2022 Highlights and Outlining our Plans for 2023
14-Sep-2022
AACR Conference Presentation
25-Aug-2022
CEO & Managing Director Presentation to AGM
25-Jul-2022
Presentation at Major Pancreatic Cancer Conference
12-May-2022
Amplia Presentation to 16th Bioshares Biotech Summit
1-Feb-2022
Amplia Investor Presentation - February 2022
16-Dec-2021
Amplia Provides Updated Investor Presentation
8-Nov-2021
Capital Raising Investor Presentation
19-Oct-2021
Amplia Provides Updated Investor Presentation
28-Sep-2021
Proactive Investors Lifesciences Webinar Presentation
15-Sep-2021
Updated Investor Presentation
27-Aug-2021
Annual General Meeting Video August 2021
28-Jul-2021
Shareholder Update Video July 2021
28-Jul-2021
Shareholder Update Slides July 2021
30-Apr-2021
Shareholder Update Slides April 2021
29-Apr-2021
Shareholder Update Video April 2021
18-Sep-2020
CEO Presentation to 2020 Annual General Meeting
2-Jun-2020
Investor Presentation
17-Dec-2019
Shareholder Update - December 2019
